Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2026-07-29 20:05:03 ET · period of report 2026-07-28 · accession 0001193125-26-324445 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-29 20:05 | 2026-07-28 | SRPT | SEVERINO MICHAEL | CEO, Dir | A - Grant | — | +756.1K | 756.1K | New | — |
| D | 2026-07-29 20:05 | 2026-07-28 | SRPT | SEVERINO MICHAEL | CEO, Dir | A - Grant | $0.00 | +2.22M | 2.22M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | A | A | 756,104 | — | 756,104 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in substantially equal installments on an annual basis over four years from the date of grant, subject to the Reporting Person's continued employment. |
| 2 | Derivative | Stock Options (right to buy) | 2026-07-28 | A | A | 2,224,342 | $0.00 | 2,224,342 | D | $17.74 · 2027-07-28 to 2036-07-28 | 2,224,342 Common Stock | (F2) Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continued employment. |